MedPath

Probiomed, S.A. de C.V.

🇲🇽Mexico
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

TREatment of degeNerative and Neoplastic Diseases With Rituximab

Phase 2
Conditions
Diffuse Large B Cell Lymphoma
First Posted Date
2011-01-14
Last Posted Date
2011-01-14
Lead Sponsor
Probiomed S.A. de C.V.
Target Recruit Count
54
Registration Number
NCT01277172
Locations
🇲🇽

INCan, Mexico, D.f., Mexico

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.